Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Avid Bioservices stock
Learn how to easily invest in Avid Bioservices stock.
Avid Bioservices is a biotechnology business based in the US. Avid Bioservices shares (CDMO) are listed on the NASDAQ and all prices are listed in US Dollars. Avid Bioservices employs 321 staff and has a trailing 12-month revenue of around $134.2 million.
How to buy Avid Bioservices stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – CDMO. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
What's in this guide?
Avid Bioservices stock price (NASDAQ: CDMO)Use our graph to track the performance of CDMO stocks over time.
Avid Bioservices shares at a glance
|Latest market close||$16.00|
|52-week range||$11.30 - $22.83|
|50-day moving average||$14.61|
|200-day moving average||$16.01|
|Wall St. target price||$22.33|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$1.68|
Buy Avid Bioservices stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Avid Bioservices stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Avid Bioservices price performance over time
|1 week (2023-01-20)||-2.74%|
|1 month (2022-12-28)||18.43%|
|3 months (2022-10-28)||-9.81%|
|6 months (2022-07-28)||-21.41%|
|1 year (2022-01-28)||-8.20%|
|2 years (2021-01-28)||13.56%|
|3 years (2020-01-28)||140.60%|
|5 years (2018-01-26)||340.77%|
Is Avid Bioservices stock undervalued or overvalued?
Valuing Avid Bioservices stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avid Bioservices's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avid Bioservices's P/E ratio
Avid Bioservices's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Avid Bioservices shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Avid Bioservices's EBITDA
Avid Bioservices's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.2 million.
The EBITDA is a measure of a Avid Bioservices's overall financial performance and is widely used to measure a its profitability.
Avid Bioservices financials
|Revenue TTM||$134.2 million|
|Operating margin TTM||3.27%|
|Gross profit TTM||$36.6 million|
|Return on assets TTM||0.74%|
|Return on equity TTM||101.81%|
|Market capitalisation||$1.1 billion|
TTM: trailing 12 months
Avid Bioservices share dividends
We're not expecting Avid Bioservices to pay a dividend over the next 12 months.
Have Avid Bioservices's shares ever split?
Avid Bioservices's shares were split on a 1:7 basis on 9 July 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avid Bioservices shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Avid Bioservices shares which in turn could have impacted Avid Bioservices's share price.
Avid Bioservices share price volatility
Over the last 12 months, Avid Bioservices's shares have ranged in value from as little as $11.3 up to $22.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avid Bioservices's is 1.8455. This would suggest that Avid Bioservices's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Avid Bioservices overview
Avid Bioservices, Inc. , a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc.
Frequently asked questionsWhat percentage of Avid Bioservices is owned by insiders or institutions?
Currently 0.656% of Avid Bioservices shares are held by insiders and 109.633% by institutions. How many people work for Avid Bioservices?
Latest data suggests 321 work at Avid Bioservices. When does the fiscal year end for Avid Bioservices?
Avid Bioservices's fiscal year ends in April. Where is Avid Bioservices based?
Avid Bioservices's address is: 2642 Michelle Drive, Tustin, CA, United States, 92780 What is Avid Bioservices's ISIN number?
Avid Bioservices's international securities identification number is: US05368M1062 What is Avid Bioservices's CUSIP number?
Avid Bioservices's Committee on Uniform Securities Identification Procedures number is: 878517309
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert